Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management

Overview of attention for article published in Clinical and Experimental Gastroenterology, June 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Effectivity and Safety Profile of Tenapanor, a Sodium-Hydrogen Exchanger Isoform 3 Inhibitor, as an Innovative Treatment for Hyperphosphatemia in Chronic Kidney Disease, a Systematic Review of Clinical Studies

Article in Nefrología (June 2024)

Raising the Bar in the Management of IBS-C.

Article in Gastroenterology & hepatology (October 2023)

Step on the accelerator: modern treatment of constipation

Article in Current Opinion in Gastroenterology (September 2023)